Junshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC Patients
TMC Subsidiary NORI Completes Key Offshore Research Campaign, Evaluating Seafloor Ecosystem Function a Year Post Nodule Collection Test
Copenhagen Infrastructure Partners signs MoU with Mexican authorities for Helax Istmo, a green hydrogen project
nCino and Salesforce Expand Strategic Partnership to Further Modernize the Financial Services Industry
Fluence Stands by its Work on the Diablo Plant, and Will Vigorously Pursue the Payments it is Owed for its Work and Dispute the Allegations in the Counterclaim Filed by the Operator of the Plant